文献速递创伤与烧伤复苏、休克与脓毒症心脑血管急症

17α-炔雌醇-3-硫酸酯提高创伤性脑损伤合并失血性休克大型动物模型的生存率与血流动力学功能:一项随机对照试验

17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial.
PubMed 文献 · Crit Care · 2021-12-16
一句话结论在猪创伤性脑损伤合并失血性休克模型中,静脉给予17α-炔雌醇-3-硫酸酯(0.2 mL/kg,5.0 mg/mL,5 min泵入)使295分钟生存率从安慰剂组的72.7%提高至90.3%。

该随机、盲法临床前研究使用80头性成熟Yucatan猪(50%雌性,190.64±21.04日龄,28.18±2.72 kg),其中68头接受闭合性加速性脑创伤并移除约40%循环血量,随机经连续泵静脉给予17α-炔雌醇-3-硫酸酯(EE-3-SO4,5.0 mg/mL,0.2 mL/kg,5 min)或安慰剂(0.45%氯化钠溶液),另12头为未受伤假手术组,所有动物在无机械通气、液体复苏等其他救命措施下监测至多5小时。结果显示EE-3-SO4组295分钟生存率为90.3%(28/31),显著高于安慰剂组的72.7%(24/33);EE-3-SO4还更快恢复脉压,但休克指数无获益。基于血液的神经炎症和血脑屏障破坏主要指标均为阴性,而弥漫性轴索损伤的次要指标提示EE-3-SO4组更快回归基线。生存状态与生物学性别(雌性>雄性)以及酸中毒和神经创伤证据相关,且独立于EE-3-SO4或安慰剂给药。作者认为EE-3-SO4在无标准疗法的院前环境(农村和军事)中有效促进多发性创伤后的生存并更快恢复心血管稳态。

要点

  • 在猪创伤性脑损伤合并失血性休克模型中,EE-3-SO4组295分钟生存率为90.3%(28/31),显著高于安慰剂组的72.7%(24/33)。
  • EE-3-SO4(5.0 mg/mL,0.2 mL/kg,5 min静脉泵入)更快恢复脉压,但休克指数无获益。
  • 基于血液的神经炎症和血脑屏障破坏主要指标均为阴性,弥漫性轴索损伤次要指标提示EE-3-SO4组更快回归基线。
  • 生存状态与生物学性别(雌性>雄性)、酸中毒和神经创伤证据相关,独立于EE-3-SO4或安慰剂给药。
  • 所有动物在无机械通气、液体复苏等其他救命措施下监测至多5小时。

适用人群与场景

  • 性成熟Yucatan猪(190.64±21.04日龄;28.18±2.72 kg),50%雌性;68头接受闭合性加速性脑创伤并移除约40%循环血量,12头为未受伤假手术组。
  • 模拟院前环境(农村和军事)且无标准疗法(如机械通气、液体复苏)的条件。

处置流程与药物剂量

  • EE-3-SO4以5.0 mg/mL浓度溶于赋形剂,按0.2 mL/kg剂量经连续泵静脉给药,5分钟内输注完毕。
  • 安慰剂组给予0.45%氯化钠溶液,同样经连续泵0.2 mL/kg、5分钟内输注。

研究设计与关键结果

  • 研究为完全随机、盲法临床前试验,使用80头性成熟Yucatan猪(50%雌性;190.64±21.04日龄;28.18±2.72 kg),其中68头接受闭合性加速性脑创伤并移除约40%循环血量,12头为未受伤假手术组。
  • EE-3-SO4组295分钟生存率为90.3%(28/31),显著高于安慰剂组的72.7%(24/33)。
  • EE-3-SO4在给药后更快速恢复脉压,但休克指数无获益。
  • 基于血液的神经炎症和血脑屏障破坏主要指标均为阴性;弥漫性轴索损伤次要指标提示EE-3-SO4组更快回归基线。
  • 生存状态与生物学性别(雌性>雄性)、酸中毒和神经创伤证据相关,独立于EE-3-SO4或安慰剂给药。

证据类型、等级与局限

  • 证据类型:随机、盲法临床前动物试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为EE-3-SO4在无标准疗法的院前环境(农村和军事)中可有效促进多发性创伤后的生存并更快恢复心血管稳态。
  • 作者建议未来研究应考虑针对额外机制(如增强止血、提高携氧能力等)的多治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury (TBI) and severe blood loss resulting in hemorrhagic shock (HS) represent leading causes of trauma-induced mortality, especially when co-occurring in pre-hospital settings where standard therapies are not readily available. The primary objective of this study was to determine if 17α-ethinyl estradiol-3-sulfate (EE-3-SO4) increases survival, promotes more rapid cardiovascular recovery, or confers neuroprotection relative to Placebo following TBI + HS.

METHODS: All methods were approved by required regulatory agencies prior to study initiation. In this fully randomized, blinded preclinical study, eighty (50% females) sexually mature (190.64 ± 21.04 days old; 28.18 ± 2.72 kg) Yucatan swine were used. Sixty-eight animals received a closed-head, accelerative TBI followed by removal of approximately 40% of circulating blood volume. Animals were then intravenously administered EE-3-SO4 formulated in the vehicle at 5.0 mg/mL (dosed at 0.2 mL/kg) or Placebo (0.45% sodium chloride solution) via a continuous pump (0.2 mL/kg over 5 min). Twelve swine were included as uninjured Shams to further characterize model pathology and replicate previous findings. All animals were monitored for up to 5 h in the absence of any other life-saving measures (e.g., mechanical ventilation, fluid resuscitation).

RESULTS: A comparison of Placebo-treated relative to Sham animals indicated evidence of acidosis, decreased arterial pressure, increased heart rate, diffuse axonal injury and blood-brain barrier breach. The percentage of animals surviving to 295 min post-injury was significantly higher for the EE-3-SO4 (28/31; 90.3%) relative to Placebo (24/33; 72.7%) cohort. EE-3-SO4 also restored pulse pressure more rapidly post-drug administration, but did not confer any benefits in terms of shock index. Primary blood-based measurements of neuroinflammation and blood brain breach were also null, whereas secondary measurements of diffuse axonal injury suggested a more rapid return to baseline for the EE-3-SO4 group. Survival status was associated with biological sex (female > male), as well as evidence of increased acidosis and neurotrauma independent of EE-3-SO4 or Placebo administration.

CONCLUSIONS: EE-3-SO4 is efficacious in promoting survival and more rapidly restoring cardiovascular homeostasis following polytraumatic injuries in pre-hospital environments (rural and military) in the absence of standard therapies. Poly-therapeutic approaches targeting additional mechanisms (increased hemostasis, oxygen-carrying capacity, etc.) should be considered in future studies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Mayer AR, Dodd AB, Rannou-Latella JG, et al. 17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial. Crit Care. 2021. PMID: 34915927. doi:10.1186/s13054-021-03844-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。